EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
183 hedge funds and large institutions have $1.16B invested in Eagle Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
5% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 60
Holders
183
Holding in Top 10
5
Calls
$14.8M
Puts
$14.4M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$19.8M | |
| 3 | +$13.9M | |
| 4 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$12.1M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$6.4M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$24.7M | |
| 3 | -$20.8M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$20.2M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$13.5M |